In this study, the immunohistochemical evaluation of Ki67 and pHH3 expressions in bladder urothelial carcinoma cases was conducted, and these marker expressions were compared with clinicopathological data and prognostic factors. This evidence concerns the gene MKI67 and bladder transitional cell carcinoma.